• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖皮质激素性骨质疏松症的组织形态计量学分析

Histomorphometric analysis of glucocorticoid-induced osteoporosis.

作者信息

Dalle Carbonare L, Bertoldo F, Valenti M T, Zenari S, Zanatta M, Sella S, Giannini S, Cascio V Lo

机构信息

Department of Biomedical and Surgical Sciences, Medicina Interna D, University of Verona, Italy.

出版信息

Micron. 2005;36(7-8):645-52. doi: 10.1016/j.micron.2005.07.009. Epub 2005 Sep 2.

DOI:10.1016/j.micron.2005.07.009
PMID:16243531
Abstract

Bone histomorphometry or quantitative histology consists of counting or measuring tissue components: cells, extracellular constituents and microarchitecture. Bone histomorphometry is the only method that allows the measurement of mineralization rate and the study of bone formation at three levels: cell, remodeling unit and tissue levels. It is a useful tool to explain the pathogenesis and cellular mechanisms of different metabolic bone diseases such as glucocorticoid-induced osteoporosis (GIO). Glucocorticoids (GC) affect calcium and bone metabolism at every level, but the main effect is the osteoblastic dysfunction. Concerning the bone formation, some histomorphometric studies have shown a depressed osteoblastic activity at a cell, bone remodeling unit, and tissue levels. In addition, there is evidence of a shortening of the period in which the osteoblasts work actively forming the bone matrix. This latter effect seems to occur after high cumulative doses of GC. With regard to the resorption, the results are still debated, but histomorphometric parameters seem to be increased in the majority of studies, at least in the first period of the GC treatment. From a structural point of view, GC seem to induce a thinning of the trabeculae without their perforation, which occurs only after high cumulative doses. Anti-resorptive treatments, such as bisphosphonates, are able to counteract the negative effects of GC on bone. In particular, along with their active working period, they prolong the lifespan of osteoblasts and osteocytes. In addition, the anti-resorptive treatments seem to extend the time for secondary mineralization through a reduction of the Activation Frequency. The latter is an intriguing mechanism of bisphosphonates in GIO that needs further ad hoc investigations.

摘要

骨组织形态计量学或定量组织学包括对组织成分进行计数或测量

细胞、细胞外成分和微结构。骨组织形态计量学是唯一能够测量矿化速率并在细胞、重塑单位和组织三个层面研究骨形成的方法。它是解释不同代谢性骨病(如糖皮质激素诱导的骨质疏松症,GIO)发病机制和细胞机制的有用工具。糖皮质激素(GC)在各个层面影响钙和骨代谢,但主要作用是成骨细胞功能障碍。关于骨形成,一些组织形态计量学研究表明,在细胞、骨重塑单位和组织层面,成骨细胞活性降低。此外,有证据表明成骨细胞积极形成骨基质的活跃工作期缩短。后一种效应似乎在高累积剂量的GC作用后出现。关于骨吸收,结果仍存在争议,但在大多数研究中,至少在GC治疗的第一阶段,组织形态计量学参数似乎有所增加。从结构角度来看,GC似乎会导致小梁变薄但不会穿孔,只有在高累积剂量后才会穿孔。抗吸收治疗,如双膦酸盐,能够抵消GC对骨的负面影响。特别是,在其活跃工作期,它们延长了成骨细胞和骨细胞的寿命。此外,抗吸收治疗似乎通过降低激活频率来延长二次矿化的时间。后者是双膦酸盐在GIO中一种有趣的机制,需要进一步进行专门研究。

相似文献

1
Histomorphometric analysis of glucocorticoid-induced osteoporosis.糖皮质激素性骨质疏松症的组织形态计量学分析
Micron. 2005;36(7-8):645-52. doi: 10.1016/j.micron.2005.07.009. Epub 2005 Sep 2.
2
[Functional mechanism of glucocorticoid in bone turnover and bone structure].[糖皮质激素在骨转换和骨结构中的作用机制]
Clin Calcium. 2006 Nov;16(11):1805-11.
3
Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis.糖皮质激素诱导性骨质疏松症和绝经后骨质疏松症中小梁骨微结构与重塑的比较。
J Bone Miner Res. 2001 Jan;16(1):97-103. doi: 10.1359/jbmr.2001.16.1.97.
4
Glucocorticoid-induced osteoporosis: an osteoblastic disease.糖皮质激素性骨质疏松症:一种成骨细胞疾病。
Aging Clin Exp Res. 2007 Jun;19(3 Suppl):5-10.
5
[Bone histology in postmenopausal osteoporosis--variations in cellular activity].绝经后骨质疏松症的骨组织学——细胞活性的变化
Acta Med Croatica. 2004;58(1):5-11.
6
[Glucocorticoids and osteoporosis].[糖皮质激素与骨质疏松症]
Vnitr Lek. 2007 Jul-Aug;53(7-8):831-40.
7
Fragility fractures in men with idiopathic osteoporosis are associated with undermineralization of the bone matrix without evidence of increased bone turnover.特发性骨质疏松症男性的脆性骨折与骨基质矿化不足有关,而无骨转换增加的证据。
Calcif Tissue Int. 2011 May;88(5):378-87. doi: 10.1007/s00223-011-9466-4. Epub 2011 Feb 12.
8
Adverse effects of corticosteroids on bone metabolism: a review.皮质类固醇对骨代谢的不良影响:综述。
PM R. 2011 May;3(5):466-71; quiz 471. doi: 10.1016/j.pmrj.2011.02.017.
9
The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment.甲状旁腺激素(PTH)对骨骼的合成代谢作用会因同时进行糖皮质激素治疗而减弱。
Bone. 2006 Aug;39(2):244-52. doi: 10.1016/j.bone.2006.01.142. Epub 2006 Feb 28.
10
Role of apoptosis in osteoporosis induced by glucocorticoids.细胞凋亡在糖皮质激素诱导的骨质疏松症中的作用。
J Endocrinol Invest. 2008 Jul;31(7 Suppl):22-7.

引用本文的文献

1
Prolonged Impact of Bisphosphonates and Glucocorticoids on Bone Mechanical Properties.双膦酸盐和糖皮质激素对骨力学性能的长期影响。
Pharmaceuticals (Basel). 2025 Jan 26;18(2):164. doi: 10.3390/ph18020164.
2
Bone Microarchitecture and Volumetric Mineral Density Assessed by HR-pQCT in Patients with 21- and 17α-Hydroxylase Deficiency.21-羟化酶和17α-羟化酶缺乏患者中通过高分辨率外周定量CT评估的骨微结构和体积骨密度
Calcif Tissue Int. 2023 Nov;113(5):515-525. doi: 10.1007/s00223-023-01132-w. Epub 2023 Oct 9.
3
Amputation for Complex Regional Pain Syndrome: Meta-Analysis and Validation of a Histopathology Scoring System.
复杂性区域疼痛综合征的截肢:组织病理学评分系统的荟萃分析和验证。
Pain Med. 2023 Apr 3;24(4):425-441. doi: 10.1093/pm/pnac168.
4
Altered type I collagen networking in osteoporotic human femoral head revealed by histomorphometric and Fourier transform infrared imaging correlated analyses.组织形态计量学和傅里叶变换红外成像相关分析揭示骨质疏松症患者股骨头Ⅰ型胶原网络的改变。
Biofactors. 2022 Sep;48(5):1089-1110. doi: 10.1002/biof.1870. Epub 2022 Jun 6.
5
Bone Health in Children with Rheumatic Disorders: Focus on Molecular Mechanisms, Diagnosis, and Management.儿童风湿性疾病的骨骼健康:关注分子机制、诊断和管理。
Int J Mol Sci. 2022 May 20;23(10):5725. doi: 10.3390/ijms23105725.
6
The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis.口服糖皮质激素与重症肌无力患者发生主要骨质疏松性骨折的风险。
Osteoporos Int. 2022 Mar;33(3):649-658. doi: 10.1007/s00198-021-06101-3. Epub 2021 Oct 3.
7
The Role of Aqueous Extract as a Bone Protective Agent, a Histomorphometric Study.水提取物作为骨保护剂的作用:一项组织形态计量学研究。
Int J Mol Sci. 2020 Oct 19;21(20):7715. doi: 10.3390/ijms21207715.
8
Trabecular Bone Score Is More Sensitive to Asthma Severity and Glucocorticoid Treatment Than Bone Mineral Density in Asthmatics.在哮喘患者中,小梁骨评分比骨密度对哮喘严重程度和糖皮质激素治疗更敏感。
Allergy Asthma Immunol Res. 2019 May;11(3):343-356. doi: 10.4168/aair.2019.11.3.343.
9
3T chemical shift-encoded MRI: Detection of altered proximal femur marrow adipose tissue composition in glucocorticoid users and validation with magnetic resonance spectroscopy.3T 化学位移编码 MRI:检测糖皮质激素使用者股骨近端骨髓脂肪组织成分的改变,并通过磁共振波谱进行验证。
J Magn Reson Imaging. 2019 Aug;50(2):490-496. doi: 10.1002/jmri.26586. Epub 2018 Dec 12.
10
The CRH-Transgenic Cushingoid Mouse Is a Model of Glucocorticoid-Induced Osteoporosis.促肾上腺皮质激素释放激素转基因库欣样小鼠是糖皮质激素诱导性骨质疏松症的模型。
JBMR Plus. 2017 Jun 28;1(1):46-57. doi: 10.1002/jbm4.10009. eCollection 2017 Aug.